BioByte 163: CRISPR Targets Cancer, Tahoe's Rhaister Model Challenges the Need for the Virtual Cell and the Bio Bottleneck is Agentic (opens in new tab)
Welcome to Decoding Bio’s BioByte: each week our writing collective highlight notable news—from the latest scientific papers to the latest funding rounds—and everything in between.
Read the original article